Retatrutide (LY-3437943): Eli Lilly Retatrutide is a biologic entity that acts as a triagonist for the gastric inhibitory polypeptide (GIP) receptor, the GLP-1 receptor and the glucagon receptor
Safety guide BPC-157 Side Effects & Safety Frequency, contraindications, and who is a good candidate Recent BPC-157 Research [PubMed] Multifunctionality and Possible Medical Application of the BPC 157 Peptide: Literature and Patent Review (2025) Comprehensive review summarizing BPC-157's biological activities, mechanism of action, and safety profile across preclinical and emerging clinical research
36 Summary Valproic acid can cause a variety of effects in overdose: ataxia, somnolence, lethargy, hepatotoxicity, hyperammonemia, acidosis and rarely pancytopenia
From a patient perspective, the benefit is simple: Its just having another form for these medications that will meet a different patient demand, either through ease of use, preference, or simply a way that the injections dont, Chrisman says